Document Detail

Role of intravitreal bevacizumab in adult onset Coats' disease.
MedLine Citation:
PMID:  21437759     Owner:  NLM     Status:  MEDLINE    
To evaluate the role of intravitreal bevacizumab in the treatment of Coats' disease diagnosed in adulthood. Prospective, interventional case series. Three patients with Coats' disease diagnosed in adulthood were managed with a single intravitreal injection of bevacizumab (1.25 mg) with peripheral laser photocoagulation 3 weeks later. All three patients had exudation at the macula (Stage 2B) along with peripheral retinal telangiectasia and aneurysms. They were followed up for 9 months. An appreciable reduction in the exudation at the macula and macular edema was observed in all cases following intravitreal bevacizumab therapy. In all patients, the visual acuity improved, and no signs of recurrence were observed at the final follow-up at 9 months. Intravitreal bevacizumab injections may be effective as an adjunctive treatment for adult-onset Coats' disease with foveal exudation along with laser photocoagulation to the peripheral retinal vascular abnormalities. Intravitreal bevacizumab was well tolerated by our patients, and no adverse effects were observed.
Neha Goel; Vinod Kumar; Anisha Seth; Usha Kaul Raina; Basudeb Ghosh
Related Documents :
19082719 - A randomized prospective trial comparing unsedated endoscopy via transnasal and transor...
17676329 - Predictors of the outcome of nasal surgery in terms of olfactory function.
21508919 - Intensive mobility training postcerebral hemispherectomy: early surgery shows best func...
21173999 - A prospective study of an aggressive warfarin dosing algorithm to reach and maintain in...
21453659 - Effect of fibula free flap harvest on the gait of head and neck cancer patients: prelim...
21437759 - Role of intravitreal bevacizumab in adult onset coats' disease.
20201169 - Retained placenta still a continuing cause of maternal morbidity and mortality.
6395279 - Comparative studies of multiple-dose cefoxitin vs. single-dose cefonicid for surgical p...
17092849 - Same efficacies of ipratropium and salbutamol in reversing methacholine-induced broncho...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2011-03-25
Journal Detail:
Title:  International ophthalmology     Volume:  31     ISSN:  1573-2630     ISO Abbreviation:  Int Ophthalmol     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-06-15     Completed Date:  2011-12-06     Revised Date:  2013-05-27    
Medline Journal Info:
Nlm Unique ID:  7904294     Medline TA:  Int Ophthalmol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  183-90     Citation Subset:  IM    
Guru Nanak Eye Centre, Maulana Azad Medical College, New Delhi, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiogenesis Inhibitors / administration & dosage*
Antibodies, Monoclonal, Humanized / administration & dosage*
Dose-Response Relationship, Drug
Fluorescein Angiography
Follow-Up Studies
Fundus Oculi
Intravitreal Injections
Laser Therapy / methods
Macula Lutea / drug effects,  pathology
Middle Aged
Retinal Telangiectasis / drug therapy*,  pathology,  surgery
Time Factors
Tomography, Optical Coherence
Reg. No./Substance:
0/Angiogenesis Inhibitors; 0/Antibodies, Monoclonal, Humanized; 2S9ZZM9Q9V/bevacizumab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Long-term reduction of laser flare values after trabeculectomy but not after cyclodestructive proced...
Next Document:  Xylanase production using agro-residue in solid-state fermentation from Bacillus pumilus ASH for bio...